what are Analysts report about: Provectus Biopharmaceuticals, Inc. (OTC:PVCT)

0
60

Some buy side analysts are also providing their Analysis on Provectus Biopharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 1 Analysts reported that the Price Target for Provectus Biopharmaceuticals, Inc. might touch $3.5 high while the Average Price Target and Low price Target is $3.5 and $3.5 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Provectus Biopharmaceuticals, Inc. got Upgrade on 7-Apr-09 where investment firm Rodman & Renshaw Upgrade the stock from Mkt Perform to Mkt Outperform.

Provectus Biopharmaceuticals, Inc. closed its last trading session at $0.03 with the loss of -44.07%. The Market Capitalization of the company stands at 3.68 Million. The Company has 52-week high of $0.54 and 52-week low of $0.01. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -67.3% where SMA50 and SMA200 are -76.48% and -94.39% respectively. The Company Touched its 52-Week High on Apr 29, 2016 and 52-Week Low on Nov 28, 2016.

The Relative Volume of the company is 9.77 and Average Volume (3 months) is 2.69 million. Provectus Biopharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Provectus Biopharmaceuticals, Inc. currently shows a Weekly Performance of -58.06%, where Monthly Performance is -69.53%, Quarterly performance is -88.06%, 6 Months performance is -96.03% and yearly performance percentage is -96.72%. Year to Date performance value (YTD perf) value is -96.13%. The Stock currently has a Weekly Volatility of 41.39% and Monthly Volatility of 25.74%.